Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT07105371
PHASE1
Patients With ALS and Other Motor Disorders Will be Treated With Umbilical or Placental Mesenchymal Cell Exosome Solution
Sponsor: The Foundation for Orthopaedics and Regenerative Medicine
View on ClinicalTrials.gov
Summary
Patients with ALS and other Motor Discorders will be treated with mesenchymal cell exosome solution.
Official title: Patients With ALS and Other Motor Discorders Will be Treated With Mesenchymal Cell Exosome Solution
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
70
Start Date
2024-07-14
Completion Date
2026-05-14
Last Updated
2026-10-16
Healthy Volunteers
No
Conditions
Interventions
BIOLOGICAL
Exosome Secretome
This is an intranasal treatment of exosomes derived from Umbilical or Placental Derived Mesenchymal Stem Cells.
Locations (2)
Prodromos Stem Cell Institute
Naples, Florida, United States
Prodromos Stem Cell Institute
Athens, Greece